4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001415889-24-025634
PRESIDENT AND CEO sold 19,375 shares at an average $40.39 ($782,610)
- PRESIDENT AND CEO acquired 19,375 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Option exercise 10b5-1 | +12,715 | $2.90 | $36,833 | 320,687 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Sale 10b5-1 | −12,715 | $39.81 | $506,121 | 307,972 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Option exercise 10b5-1 | +2,310 | $2.90 | $6,692 | 310,282 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Sale 10b5-1 | −2,310 | $40.70 | $94,022 | 307,972 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Option exercise 10b5-1 | +600 | $2.90 | $1,738 | 308,572 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Sale 10b5-1 | −600 | $41.61 | $24,968 | 307,972 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Option exercise 10b5-1 | +3,750 | $2.90 | $10,863 | 311,722 | D |
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Sale 10b5-1 | −3,750 | $42.00 | $157,500 | 307,972 | D |
| Derivatives | |||||||
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 772,962 | D | ||
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 771,087 | D | ||
| Fordyce Marshall PRESIDENT AND CEO | 2024-10-23 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 769,212 | D | ||
| Open-market sales · 19,375 sh · avg $40.39 · $782,610 | |||||||
Loading xslF345X05/form4-10252024_081055.xml…